VIEMED HEALTHCARE INC
For the period ended Sep 30, 2024. Filed Nov 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 6, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Shareholders' Equity
VIEMED HEALTHCARE, INC.CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(Expressed in thousands of U.S. Dollars, except share and per share amounts)(Unaudited)
| Common Stock · Additional paid-in capital · Noncontrolling interest in subsidiary · Total Shareholders'equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Retained earnings | |||||||||||
| Shareholders' equity, December 31, 2022 | 38,049,739 | $15,123 | $12,125 | $69,846 | $— | $97,094 | |||||
| Stock-based compensation - options | — | — | 348 | — | — | 348 | |||||
| Stock-based compensation - restricted stock | — | — | 1043 | — | — | 1,043 | |||||
| Exercise of options | 108,370 | 544 | — | — | — | 544 | |||||
| Shares issued for vesting of restricted stock units | 183,036 | 1,429 | (1,429) | — | — | — | |||||
| Shares redeemed to pay income tax | (64,756) | — | — | (505) | — | (505) | |||||
| Net income | — | — | — | 1,517 | — | 1,517 | |||||
| Shareholders' equity, March 31, 2023 | 38,276,389 | $17,096 | $12,087 | $70,858 | $— | $100,041 | |||||
| Stock-based compensation - options | — | — | 301 | — | — | 301 | |||||
| Stock-based compensation - restricted stock | — | — | 1,170 | — | — | 1,170 | |||||
| Exercise of options | 119,356 | 684 | — | — | — | 684 | |||||
| Shares issued for vesting of restricted stock units | 6,655 | 70 | (70) | — | — | — | |||||
| Shares redeemed to pay income tax | (1,978) | — | — | (21) | — | (21) | |||||
| Net income | — | — | — | 2,330 | — | 2,330 | |||||
| Shareholders' equity, June 30, 2023 | 38,400,422 | $17,850 | $13,488 | $73,167 | $— | $104,505 | |||||
| Stock-based compensation - options | — | — | 263 | — | — | 263 | |||||
| Stock-based compensation - restricted stock | — | — | 1,190 | — | — | 1,190 | |||||
| Exercise of options | 1,136 | 6 | — | — | — | 6 | |||||
| Shares issued for vesting of restricted stock units | 95,944 | 777 | (777) | — | — | — | |||||
| Shares redeemed to pay income tax | (8,501) | — | — | (69) | — | (69) | |||||
| Net income | — | — | — | 2,919 | — | 2,919 | |||||
| Shareholders' equity, September 30, 2023 | 38,489,001 | $18,633 | $14,164 | $76,017 | $— | $108,814 | |||||
See accompanying notes to the condensed consolidated financial statements
Page 5
VIEMED HEALTHCARE, INC.CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(Expressed in thousands of U.S. Dollars, except share and per share amounts)(Unaudited)
| Common Stock · Additional paid-in capital · Noncontrolling interest in subsidiary · Total Shareholders'equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Retained earnings | |||||||||||
| Shareholders' equity, December 31, 2023 | 38,506,161 | $18,702 | $15,698 | $79,495 | $— | $113,895 | |||||
| Stock-based compensation - options | — | — | 111 | — | — | 111 | |||||
| Stock-based compensation - restricted stock | — | — | 1,321 | — | — | 1,321 | |||||
| Exercise of options | 60,130 | 304 | — | — | — | 304 | |||||
| Shares issued for vesting of restricted stock units | 378,837 | 2,836 | (2,836) | — | — | — | |||||
| Shares redeemed to pay income tax | (128,362) | — | — | (961) | — | (961) | |||||
| Net income | — | — | — | 1,603 | — | 1,603 | |||||
| Shareholders' equity, March 31, 2024 | 38,816,766 | $21,842 | $14,294 | $80,137 | $— | $116,273 | |||||
| Stock-based compensation - options | — | — | 59 | — | — | 59 | |||||
| Stock-based compensation - restricted stock | — | — | 1,561 | — | — | 1,561 | |||||
| Exercise of options | 4,000 | 21 | — | — | — | 21 | |||||
| Shares issued for vesting of restricted stock units | 6,654 | 47 | (47) | — | — | — | |||||
| Shares redeemed to pay income tax | (1,621) | — | — | (11) | — | (11) | |||||
| Acquired noncontrolling interest | — | — | — | — | 1,800 | 1,800 | |||||
| Net income | — | — | — | 1,468 | 9 | 1,477 | |||||
| Shareholders' equity, June 30, 2024 | 38,825,799 | $21,910 | $15,867 | $81,594 | $1,809 | $121,180 | |||||
| Stock-based compensation - options | — | — | 61 | — | — | 61 | |||||
| Stock-based compensation - restricted stock | — | — | 1,651 | — | — | 1,651 | |||||
| Exercise of options | 17,516 | 91 | — | — | — | 91 | |||||
| Shares issued for vesting of restricted stock units | 101,438 | 748 | (748) | — | — | — | |||||
| Shares redeemed to pay income tax | (12,506) | — | — | (93) | — | (93) | |||||
| Net income | — | — | — | 3,878 | 27 | 3,905 | |||||
| Shareholders' equity, September 30, 2024 | 38,932,247 | $22,749 | $16,831 | $85,379 | $1,836 | $126,795 | |||||
See accompanying notes to the condensed consolidated financial statements
Page 6
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.